Ivor Elrifi, CEO of Tiziana Life Sciences, expressed enthusiasm about this milestone, stating, "We are excited to initiate this important clinical study with the support of the ALS Association grant.
NEW YORK, March 04, 2025) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully hu ...
Experts warn that excessive saliva, or drooling, could be a potential indicator of motor neurone disease (MND), a condition ...
The experts say if you notice that you produce a "lot of saliva (drool)", then this could indicate motor neurone disease (MND ...
Find out about the new ALS blood test that offers accurate diagnosis and could replace traditional invasive testing methods.
Measuring blood levels of NfL, a biomarker of nerve damage, could help diagnose ALS and predict the risk of death for ...
Stress granules (SGs) are transient organelles that form when cells experience stress, serving as critical hubs for RNA metabolism and cellular survival.
"Receiving orphan drug designation from the FDA is a significant milestone for DiagnaMed and validates the promise of molecular hydrogen as a potential treatment for ALS. We are excited to partner ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback